Peripheral Neuropathy Market Analysis and Forecast to 2030 Report

Description

Peripheral Neuropathy Market Report Highlights:

Key Segments: Pain relievers, Anti-seizure medicines, TENS, Induced peripheral neuropathy, Mononeuropathy.

Key Companies: Pfizer, NeuroMetrix, Inc., Eli Lilly and Company, WinSanTor, Inc., Johnson & Johnson Services, Inc.

Geographies: USA, China, UK, Japan, Germany, France, Italy, Spain, The Netherlands, Canada, India, South Korea, Australia, New Zealand, Middle East, Africa, South and Central America

Historical Data: 2018-2020

Forecasting Period: 2021-2030

Research Methods: Primary Research, Secondary Research, COVID-19 Impact Analysis

Forecast Methods: Market Research, Trend Projections, Panel Consensus, Historical Analogy

Pages and Exhibits: 150+ pages, 60+ Statistical Tables, 25+ Analysis Figures

Market Currency: US Dollar ($)

Report Language: English

Report Format: Online, Downloadable PDF, Excel

Available Customizations: Manufacturer Side Report, Distributor Side Report, End-User Side Report, Thought Leadership Report

Peripheral Neuropathy Market Definition:

Peripheral Neuropathy refers to a medical condition that involves damage to peripheral nervous system and can be treated at hospitals, ambulatory care or home care. The peripheral neuropathy can be majorly divided into mononeuropathy and induced peripheral neuropathy. This condition can be treated with medications such as pain relievers, antidepressants, etc, and various medical devices such as transcutaneous electrical nerve stimulation (TENS), assistive devices, among others.

Peripheral Neuropathy Market Segmentation:

Peripheral Neuropathy Market, by Product	Medication Pain Relievers Anti-seizure Medication Topical Medication Antidepressants Others Medical Devices Transcutaneous electrical nerve stimulation (TENS) Assistive Devices Physical Therapy Devices Surgical Equipment Screening Devices Others
Peripheral Neuropathy Market, by Type of Neuropathy	Mononeuropathy Induced Peripheral Neuropathy Diabetes Induced Peripheral Neuropathy Chemotherapy Induced Peripheral Neuropathy HIV-Induced Peripheral Neuropathy Drug Induced Peripheral Neuropathy Others
Peripheral Neuropathy Market, by End User	Hospitals & Clinic Ambulatory Care Home Care
Peripheral Neuropathy Market Major Companies	WinSanTor, Inc. RxFunction, Inc. Diabetik Foot Care India Pvt Limited Owen Mumford Johnson & Johnson Services, Inc. Pfizer NeuroMetrix, Inc. Alfasigma USA, Inc. Eli Lilly and Company REGENACY PHARMACEUTICALS, INC. Qutenza Axosim Others
Peripheral Neuropathy Market, By Geography	North America USA Canada South and Central America Europe Germany France K. Italy Spain The Netherlands Rest of Europe Asia-Pacific China Japan India South Korea Australia New-Zealand Rest of Asia-Pacific Middle East & Africa

 

Peripheral Neuropathy Market Report: Table of Content and Chapter Description:

1. Peripheral Neuropathy Market Summary

This section includes summary of whole report. It majorly includes brief analysis of market numbers, various forecast factors and market dynamics such as drivers, restraints, opportunities, and key trends. In addition to this, this section also talks about leading players operating in the market.

2. Report Inclusion & Exclusion

This section provides brief idea about the factors included in the study, along with the factors which are not considered in the study. It helps the reader to have better understanding of the provided information.

3. Market Dynamics

This section provides detailed analysis of drivers, restraints, opportunities, and threats which have significant impact on the growth of the market. It also includes key trends influencing the market growth and demand.

4. Key Market Insights

This section majorly includes analysis of micro and macro-economic indicators that would have direct or indirect impact on the market growth. This section also includes pricing analysis, product pipeline analysis, PORTER’S five forces analysis, PESTLE analysis, funding analysis, among others.

5. COVID-19 Impact Analysis

This section provides detailed analysis of pre and post COVID-19 pandemic impact on the market. The section provides effect of COVID-19 during 2020 and 2021, and also provides recovery scenario. In addition to this, it also analyzes impact of vaccination drive on the market recovery.

6. Peripheral Neuropathy Market Analysis and Forecast to 2030, by Product

This section provides detailed country level market estimations and analysis of Peripheral Neuropathy, by Product. The segments majorly include Medications and Medical Devices and others.

7. Peripheral Neuropathy Market Analysis and Forecast to 2030, by Type of Neuropathy

This report segment includes detailed country level market estimations and forecast for various Types of neuropathy. The segments includes analysis of Mononeuropathy, and Induced peripheral neuropathy.

8. Peripheral Neuropathy Market Analysis and Forecast to 2030, by End User

This section includes revenue estimation, forecast and detailed analysis of Peripheral Neuropathy based on end users at country level. The segments consist of Hospitals & Clinics, Ambulatory Care, and Home Care.

9. Competition Analysis

This section provides detailed analysis of key companies operating in this market. It includes, products/services ranking, market positioning, company competition matrix, impact analysis, market share analysis, and each company’s overviews.

10. Appendix

10.1 Peripheral Neuropathy Market: Research Methodology

This section includes detailed explanation of various techniques used during market estimation. It majorly involves primary and secondary research. Primary research involves interviews with industry personals and key opinion leaders from respective sectors, while secondary research includes data gathering through internet search, databases such as Bloomberg, FactSet, among others. In addition to this, the section also involves explanation of data forecast models used during the study.

10.2 Appendix

10.3 Abbreviations

**Note: Table of Content/ Scope of work subject to change as per client requirements and research updates.